BACKGROUND Chromosomal Xq28 region duplication encompassing methyl-CpG-binding protein 2(MECP2)results in an identifiable phenotype and global developmental delay known as MECP2 duplication syndrome(MDS).This syndrome...BACKGROUND Chromosomal Xq28 region duplication encompassing methyl-CpG-binding protein 2(MECP2)results in an identifiable phenotype and global developmental delay known as MECP2 duplication syndrome(MDS).This syndrome has a wide range of clinical manifestations,including abnormalities in appearance,neurodevelopment,and gastrointestinal motility;recurrent infections;and spasticity.Here,we report a case of confirmed MDS at our institution.CASE SUMMARY A 12-year-old Chinese boy presented with intellectual disability(poor intellectual[reasoning,judgment,abstract thinking,and learning]and adaptive[lack of communication and absent social skills,apraxia,and ataxia]functioning)and dysmorphism.He had no history of recurrent infections,seizures,or bowel dysfunction,which is different from that in reported cases.Microarray comparative genomic hybridization confirmed MECP2 duplication in the patient and his mother who is a carrier.The duplication size was the same in the patient and his mother.No prophylactic antibiotic or anti-seizure therapy was offered to the patient or his mother before or after the consultation.CONCLUSION MDS is rare and has various clinical presentations.Clinical suspicion is critical in patients presenting with developmental delays.展开更多
Melatonin is a pleiotropic molecule that,after a short-term sleep deprivation,promotes the proliferation of neural stem cells in the adult hippocampus.However,this effect has not been observed in long-term sleep depri...Melatonin is a pleiotropic molecule that,after a short-term sleep deprivation,promotes the proliferation of neural stem cells in the adult hippocampus.However,this effect has not been observed in long-term sleep deprivation.The precise mechanism exerted by melatonin on the modulation of neural stem cells is not entirely elucidated,but evidence indicates that epigenetic regulators may be involved in this process.In this study,we investigated the effect of melatonin treatment during a 96-hour sleep deprivation and analyzed the expression of epigenetic modulators predicted by computational text mining and keyword clusterization.Our results showed that the administration of melatonin under sleep-deprived conditions increased the MECP2 expression and reduced the SIRT1 expression in the dentate gyrus.We observed that let-7 b,mir-132,and mir-124 were highly expressed in the dentate gyrus after melatonin administration,but they were not modified by sleep deprivation.In addition,we found more Sox2^+/5-bromo-2’-deoxyuridine(BrdU)^+cells in the subgranular zone of the sleep-deprived group treated with melatonin than in the untreated group.These findings may support the notion that melatonin modifies the expression of epigenetic mediators that,in turn,regulate the proliferation of neural progenitor cells in the adult dentate gyrus under long-term sleep-deprived conditions.All procedures performed in this study were approved by the Animal Ethics Committee of the University of Guadalajara,Mexico(approval No.CI-16610)on January 2,2016.展开更多
X-linked methyl-CpG binding protein 2 mutations can induce symptoms similar to those of Parkinson’s disease and dopamine metabolism disorders, but the specific role of X-linked methyl-CpG binding protein 2 in the pat...X-linked methyl-CpG binding protein 2 mutations can induce symptoms similar to those of Parkinson’s disease and dopamine metabolism disorders, but the specific role of X-linked methyl-CpG binding protein 2 in the pathogenesis of Parkinson’s disease remains unknown. In the present study, we used 6-hydroxydopamine-induced human neuroblastoma cell （SH-SY5Y cells） injury as a cell model of Parkinson’s disease. The 6-hydroxydopamine （50 μmol/L） treatment decreased protein levels for both X-linked methyl-CpG binding protein 2 and tyrosine hydroxylase in these cells, and led to cell death. However, overexpression of X-linked methyl-CpG binding protein 2 was able to ameliorate the effects of 6-hydroxydopamine, it reduced 6-hydroxydopamine-induced apoptosis, and increased the levels of tyrosine hydroxylase in SH-SY5Y cells. These findings suggesting that X-linked methyl-CpG binding protein 2 may be a potential therapeutic target for the treatment of Parkinson’s disease.展开更多
Methyl-CpG-binding protein 2(MeCP2),encoded by the gene MECP2,is a transcriptional regulator and chromatinremodeling protein,which is ubiquitously expressed and plays an essential role in the development and maintenan...Methyl-CpG-binding protein 2(MeCP2),encoded by the gene MECP2,is a transcriptional regulator and chromatinremodeling protein,which is ubiquitously expressed and plays an essential role in the development and maintenance of the central nervous system(CNS).Highly enriched in post-migratory neurons,MeCP2 is needed for neuronal maturation,including dendritic arborization and the development of synapses.Loss-of-function mutations in MECP2 cause Rett syndrome(RTT),a debilitating neurodevelopmental disorder characterized by a phase of normal development,followed by the progressive loss of milestones and cognitive disability.While a great deal has been discovered about the structure,function,and regulation of MeCP2 in the time since its discovery as the genetic cause of RTT,including its involvement in a number of RTT-related syndromes that have come to be known as MeCP2-spectrum disorders,much about this multifunctional protein remains enigmatic.One unequivocal fact that has become apparent is the importance of maintaining MeCP2 protein levels within a narrow range,the limits of which may depend upon the cell type and developmental time point.As such,MeCP2 is amenable to complex,multifactorial regulation.Here,we summarize the role of the MECP23'untranslated region(UTR)in the regulation of MeCP2 protein levels and how mutations in this region contribute to autism and other non-RTT neuropsychiatric disorders.展开更多
背景甲基化CpG结合蛋白2(methyl-CpG-binding protein 2,MeCP2)在基因转录调控中发挥重要作用,研究表明MeCP2可能是胶质瘤治疗的一个新靶点,但其在胶质瘤中的表达与患者预后的关系尚不清楚。目的探讨MeCP2在胶质瘤中的表达与患者手术后...背景甲基化CpG结合蛋白2(methyl-CpG-binding protein 2,MeCP2)在基因转录调控中发挥重要作用,研究表明MeCP2可能是胶质瘤治疗的一个新靶点,但其在胶质瘤中的表达与患者预后的关系尚不清楚。目的探讨MeCP2在胶质瘤中的表达与患者手术后临床预后的关系。方法选择2016年1月—2018年10月在贵阳市第二人民医院神经外科手术治疗的临床病理资料完整的96例胶质瘤患者,应用免疫组织化学方法检测肿瘤组织和正常脑组织中MeCP2的表达,随访患者生存情况。采用Kaplan-Meier法进行生存分析;采用Cox单因素和多因素风险回归模型分析MeCP2表达水平及相关临床病理因素与患者生存预后的关系。结果96例患者获得随访,其中男51例,女45例,年龄7~79岁,平均年龄(44.9±18.3)岁。免疫组化结果显示胶质瘤组织中MeCP2阳性表达率高于正常脑组织(75.0%vs 30.0%,P<0.05)。MeCP2表达的阳性率在WHOⅠ~Ⅳ级胶质瘤组织中分别为20.0%、66.7%、75.0%、90.6%(1/5、18/27、24/32、29/32),在高级别胶质瘤(WHOⅢ、Ⅳ级)中的阳性表达率高于低级别胶质瘤(WHOⅠ、Ⅱ级),差异有统计学意义(P<0.05)。70例出现肿瘤复发,59例死亡,中位无进展生存期(progression-free survival,PFS)和总生存期(overall survival,OS)分别为(10.7±1.7)个月和(24.1±2.9)个月。Kaplan-Meier生存分析显示,胶质瘤患者中MeCP2高表达组的中位PFS和OS显著低于低表达组[PFS:(15.6±1.8)个月vs(28.0±2.6)个月,P=0.026;OS:(16.1±2.0)个月vs(28.3±5.8)个月,P=0.022]。Cox回归分析显示,MeCP2高表达(HR:1.705,95%CI:1.019~2.854)、肿瘤病变多发(HR:2.727,95%CI:1.453~5.120)、单纯采用手术治疗(HR:1.704,95%CI:1.015~2.861)、高病理级别(WHOⅢ、Ⅳ级)(HR:3.294,95%CI:2.317~4.683)是胶质瘤患者预后不良的独立危险因素。结论MeCP2在胶质瘤手术患者中表达水平上调,且高表达水平与胶质瘤患者术后不良预后相关。展开更多
目的明确中国Rett综合征（Rett syndrome，RTT）患儿致病基因甲基化CpG结合蛋白2（methyl-CpG-binding protein 2，MECP2）的突变亲源。方法对115例经基因突变分析证实存在MECP2突变的患儿进行第3内含子测序分析，寻找单核苷酸多态性（s...目的明确中国Rett综合征（Rett syndrome，RTT）患儿致病基因甲基化CpG结合蛋白2（methyl-CpG-binding protein 2，MECP2）的突变亲源。方法对115例经基因突变分析证实存在MECP2突变的患儿进行第3内含子测序分析，寻找单核苷酸多态性（single nucleotide polymorphism，SNP）位点。对发现SNP患儿行等位基因特异性PCR扩增，通过比较患儿及其父亲SNP碱基序列，判定患儿突变基因所在染色体亲源。结果115例患儿中76例存在至少一种SNP。在中国RTT患儿中发现3个热点SNP。76例患儿中73例突变位于父源X染色体，3例突变位于母源X染色体。结论我国RTT患儿MECP2突变以父源突变为主。展开更多
目的探讨甲基CpG结合蛋白2(methyl-CpG-binding protein 2,MeCP2)基因单核苷酸多态性与中国长江以南汉族人群系统性红斑狼疮(systemic lupus erythematosus,SLE)的易感性。方法采用病例对照研究设计,收集病例141例,对照144例。应用聚合...目的探讨甲基CpG结合蛋白2(methyl-CpG-binding protein 2,MeCP2)基因单核苷酸多态性与中国长江以南汉族人群系统性红斑狼疮(systemic lupus erythematosus,SLE)的易感性。方法采用病例对照研究设计,收集病例141例,对照144例。应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术对rs2239464、rs2075596两位点进行基因分型,在不同的遗传模式下分析两个位点基因多态性与SLE的相关性。根据赤池信息准则(Akaike’s information criteria,AIC)值最小原则,筛选最优模型。结果在显性、隐性、相加及相乘遗传模式下,两位点基因型或等位基因频率分布在病例组与对照组间的差异均有统计学意义(P<0.05)。显性遗传模式下,rs2239464、rs2075596位点GG/AG基因型为SLE的保护性基因型(ORrs2239464=0.528,95%CIrs2239464:0.315～0.885;ORrs2075596=0.435,95%CIrs2075596:0.264～0.717)。隐性遗传模式下,rs2239464、rs2075596位点GG基因型在统计学上具有显著的保护性作用(ORrs2239464=0.108,95%CIrs2239464:0.013～0.863;ORrs2075596=0.097,95%CIrs2075596:0.012～0.771)。相加遗传模式下,以AA基因型为参照,rs2239464位点GG基因型为SLE的保护性基因型(OR=0.094,95%CI:0.012～0.758),rs2075596位点AG及GG基因型也具有保护性作用(ORAG=0.498,95%CIAG:0.298～0.832;ORGG=0.077,95%CIGG:0.010～0.612)。相乘遗传模式下,rs2239464、rs2075596两位点的G等位基因为SLE的保护性等位基因(ORrs2239464=0.503,95%CIrs2239464:0.319～0.793;ORrs2075596=0.445,95%CIrs2075596:0.289～0.686)。rs2239464,rs2075596位点的最优遗传模式均为相加遗传模式。结论在中国长江以南汉族人群中MECP2基因rs2239464,rs2075596位点基因多态性与SLE相关,突变等位基因G可能是SLE保护性等位基因。展开更多
文摘BACKGROUND Chromosomal Xq28 region duplication encompassing methyl-CpG-binding protein 2(MECP2)results in an identifiable phenotype and global developmental delay known as MECP2 duplication syndrome(MDS).This syndrome has a wide range of clinical manifestations,including abnormalities in appearance,neurodevelopment,and gastrointestinal motility;recurrent infections;and spasticity.Here,we report a case of confirmed MDS at our institution.CASE SUMMARY A 12-year-old Chinese boy presented with intellectual disability(poor intellectual[reasoning,judgment,abstract thinking,and learning]and adaptive[lack of communication and absent social skills,apraxia,and ataxia]functioning)and dysmorphism.He had no history of recurrent infections,seizures,or bowel dysfunction,which is different from that in reported cases.Microarray comparative genomic hybridization confirmed MECP2 duplication in the patient and his mother who is a carrier.The duplication size was the same in the patient and his mother.No prophylactic antibiotic or anti-seizure therapy was offered to the patient or his mother before or after the consultation.CONCLUSION MDS is rare and has various clinical presentations.Clinical suspicion is critical in patients presenting with developmental delays.
基金supported by grants from Universidad de Guadalajara(PROSNI 2016,2017-8)to REGCpartially by grants from Consejo Nacional de Ciencia y Tecnologia(CONACyT No.PN 2016-01-465 and INFR-280414)+1 种基金PRODEP(213544)to OGPthe CONACyT Fellowship grant(374823)to AHG
文摘Melatonin is a pleiotropic molecule that,after a short-term sleep deprivation,promotes the proliferation of neural stem cells in the adult hippocampus.However,this effect has not been observed in long-term sleep deprivation.The precise mechanism exerted by melatonin on the modulation of neural stem cells is not entirely elucidated,but evidence indicates that epigenetic regulators may be involved in this process.In this study,we investigated the effect of melatonin treatment during a 96-hour sleep deprivation and analyzed the expression of epigenetic modulators predicted by computational text mining and keyword clusterization.Our results showed that the administration of melatonin under sleep-deprived conditions increased the MECP2 expression and reduced the SIRT1 expression in the dentate gyrus.We observed that let-7 b,mir-132,and mir-124 were highly expressed in the dentate gyrus after melatonin administration,but they were not modified by sleep deprivation.In addition,we found more Sox2^+/5-bromo-2’-deoxyuridine(BrdU)^+cells in the subgranular zone of the sleep-deprived group treated with melatonin than in the untreated group.These findings may support the notion that melatonin modifies the expression of epigenetic mediators that,in turn,regulate the proliferation of neural progenitor cells in the adult dentate gyrus under long-term sleep-deprived conditions.All procedures performed in this study were approved by the Animal Ethics Committee of the University of Guadalajara,Mexico(approval No.CI-16610)on January 2,2016.
基金sponsored by the Ph.D.Independent Research Projects of Wuhan University,No.201130302020017a grant from the Science and Technology Bureau of Hubei Province,No.2011CDB511the National Natural Science Foundation of China,No.81170769
文摘X-linked methyl-CpG binding protein 2 mutations can induce symptoms similar to those of Parkinson’s disease and dopamine metabolism disorders, but the specific role of X-linked methyl-CpG binding protein 2 in the pathogenesis of Parkinson’s disease remains unknown. In the present study, we used 6-hydroxydopamine-induced human neuroblastoma cell （SH-SY5Y cells） injury as a cell model of Parkinson’s disease. The 6-hydroxydopamine （50 μmol/L） treatment decreased protein levels for both X-linked methyl-CpG binding protein 2 and tyrosine hydroxylase in these cells, and led to cell death. However, overexpression of X-linked methyl-CpG binding protein 2 was able to ameliorate the effects of 6-hydroxydopamine, it reduced 6-hydroxydopamine-induced apoptosis, and increased the levels of tyrosine hydroxylase in SH-SY5Y cells. These findings suggesting that X-linked methyl-CpG binding protein 2 may be a potential therapeutic target for the treatment of Parkinson’s disease.
基金We want to thank the support from NIH-NINDS F31NS084551 NRSA predoctoral fellowship and the Jérôme LeJeune Foundation.
文摘Methyl-CpG-binding protein 2(MeCP2),encoded by the gene MECP2,is a transcriptional regulator and chromatinremodeling protein,which is ubiquitously expressed and plays an essential role in the development and maintenance of the central nervous system(CNS).Highly enriched in post-migratory neurons,MeCP2 is needed for neuronal maturation,including dendritic arborization and the development of synapses.Loss-of-function mutations in MECP2 cause Rett syndrome(RTT),a debilitating neurodevelopmental disorder characterized by a phase of normal development,followed by the progressive loss of milestones and cognitive disability.While a great deal has been discovered about the structure,function,and regulation of MeCP2 in the time since its discovery as the genetic cause of RTT,including its involvement in a number of RTT-related syndromes that have come to be known as MeCP2-spectrum disorders,much about this multifunctional protein remains enigmatic.One unequivocal fact that has become apparent is the importance of maintaining MeCP2 protein levels within a narrow range,the limits of which may depend upon the cell type and developmental time point.As such,MeCP2 is amenable to complex,multifactorial regulation.Here,we summarize the role of the MECP23'untranslated region(UTR)in the regulation of MeCP2 protein levels and how mutations in this region contribute to autism and other non-RTT neuropsychiatric disorders.
文摘目的探讨甲基CpG结合蛋白2(methyl-CpG-binding protein 2,MeCP2)基因单核苷酸多态性与中国长江以南汉族人群系统性红斑狼疮(systemic lupus erythematosus,SLE)的易感性。方法采用病例对照研究设计,收集病例141例,对照144例。应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术对rs2239464、rs2075596两位点进行基因分型,在不同的遗传模式下分析两个位点基因多态性与SLE的相关性。根据赤池信息准则(Akaike’s information criteria,AIC)值最小原则,筛选最优模型。结果在显性、隐性、相加及相乘遗传模式下,两位点基因型或等位基因频率分布在病例组与对照组间的差异均有统计学意义(P<0.05)。显性遗传模式下,rs2239464、rs2075596位点GG/AG基因型为SLE的保护性基因型(ORrs2239464=0.528,95%CIrs2239464:0.315～0.885;ORrs2075596=0.435,95%CIrs2075596:0.264～0.717)。隐性遗传模式下,rs2239464、rs2075596位点GG基因型在统计学上具有显著的保护性作用(ORrs2239464=0.108,95%CIrs2239464:0.013～0.863;ORrs2075596=0.097,95%CIrs2075596:0.012～0.771)。相加遗传模式下,以AA基因型为参照,rs2239464位点GG基因型为SLE的保护性基因型(OR=0.094,95%CI:0.012～0.758),rs2075596位点AG及GG基因型也具有保护性作用(ORAG=0.498,95%CIAG:0.298～0.832;ORGG=0.077,95%CIGG:0.010～0.612)。相乘遗传模式下,rs2239464、rs2075596两位点的G等位基因为SLE的保护性等位基因(ORrs2239464=0.503,95%CIrs2239464:0.319～0.793;ORrs2075596=0.445,95%CIrs2075596:0.289～0.686)。rs2239464,rs2075596位点的最优遗传模式均为相加遗传模式。结论在中国长江以南汉族人群中MECP2基因rs2239464,rs2075596位点基因多态性与SLE相关,突变等位基因G可能是SLE保护性等位基因。
